Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29485570 | 1.00 | GAA (0.41) | GAANPSR1APPSERPINE1CYP4F2 | |
| SCHEMBL3400004 | 0.96 | GAA (0.43) | GAANPSR1APPCYP4F2CYP4A11 | |
| SCHEMBL9565485 | 0.85 | GAA (0.41) | GAANPSR1APPSERPINE1CYP4F2 | |
| Triethylene Glycol SCHEMBL2953401 | 0.83 | NPSR1 (0.49) | GAANPSR1ALDH1A1MAPTKDM4E | |
| SCHEMBL28435401 | 0.81 | APP (0.36) | GAAAPPCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL29359286 | 0.80 | NPSR1 (0.58) | GAANPSR1ALDH1A1MAPTKDM4E | |
| SCHEMBL6659557 | 0.80 | NPSR1 (0.58) | GAANPSR1ALDH1A1MAPTKDM4E | |
| SCHEMBL10704454 | 0.80 | GAA (0.50) | GAANPSR1APPALDH1A1MAPT | |
| SCHEMBL5318357 | 0.78 | DGKA (0.41) | GAANPSR1APPCYP4F2CYP4A11 | |
| SCHEMBL30854785 | 0.78 | DGKA (0.41) | GAANPSR1APPCYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2534202-B1 | POLYMER COMPOSITION | MITSUBISHI CHEMICAL EUROPE GMBH (DE) | 2022-04-27 | — | — | EP | claimed |
| EP-1846367-B1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | EVONIK DEGUSSA GMBH (DE) | 2016-03-09 | — | — | EP | claimed |
| EP-2534202-A1 | POLYMER COMPOSITION | Mitsubishi Chemical Europe GmbH (DE) | 2012-12-19 | — | — | EP | claimed |
| WO-2011095632-A1 | POLYMER COMPOSITION | MITSUBISHI CHEMICAL EUROPE GMBH (DE) | 2011-08-11 | — | — | WO | claimed |
| US-20100168329-A1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | DEGUSSA GMBH (DE) | 2010-07-01 | — | — | US | claimed |
| EP-0323244-B1 | ACRYLONITRILE MALEIMIDES SOLUTION COMPOSITION OF IMPROVED SHELF LIFE AND METHOD FOR PRODUCTION THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 1993-08-04 | — | — | EP | claimed |
| JP-11021416-A | — | — | None | — | — | JP | disclosed |
| JP-6179798-A | — | — | None | — | — | JP | disclosed |
| US-11807745-B2 | Interior automotive part | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-11-07 | — | — | US | disclosed |
| WO-2023078602-A1 | METHOD FOR STABILISATION OF POLYMER MATERIALS. | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-11 | — | — | WO | disclosed |
| EP-3559109-B1 | INTERIOR AUTOMOTIVE PART | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-03-15 | — | — | EP | disclosed |
| EP-3820938-B1 | PHOTOVOLTAIC ELEMENT AND POLYMER COMPOSITION FOR FRONT SHEET THEREOF | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2022-06-01 | — | — | EP | disclosed |
| EP-2534202-B1 | POLYMER COMPOSITION | MITSUBISHI CHEMICAL EUROPE GMBH (DE) | 2022-04-27 | — | — | EP | disclosed |
| EP-0645372-B1 | Stable polyisocyanate mixtures prepared by phosgen-free processes and a process for their preparation | BASF AG (DE) | 1996-12-04 | — | — | EP | disclosed |
| EP-0643042-B1 | Storage-stable polyisocyanate mixtures prepared by phosgen-free processes, a process for their preparation and their use | BASF AG (DE) | 1996-07-17 | — | — | EP | disclosed |
| EP-0645372-A1 | Stable polyisocyanate mixtures prepared by phosgen-free processes and a process for their preparation | BASF Aktiengesellschaft (DE) | 1995-03-29 | — | — | EP | disclosed |
| EP-0643042-A1 | Storage-stable polyisocyanate mixtures prepared by phosgen-free processes, a process for their preparation and their use | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | disclosed |
| JP-H06179798-A | POLYACETAL RESIN COMPOSITION | ASAHI CHEM IND CO LTD | 1994-06-28 | — | — | JP | disclosed |
| US-5102939-A | Stabilizing mixture of sulfur containing elastic thermoplastic graft product, phenolic antioxidants with nitrogen or phosphorus containg organic compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1992-04-07 | — | — | US | disclosed |
| US-4918124-A | Synergistic mixture of phenolic antioxidant and sulfur containing polymer | BAYER AKTIENGESELLSCHAFT (DE) | 1990-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168329-A1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | DDT, AADAC, SCD | GAA 405/4885NPSR1 718/4885APP 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.